Skip to content
sellWeak cluster of 310b5-1 plan

Roberto Wandenkolk Vieira sold $30k of CORT

President, Oncology at CORCEPT THERAPEUTICS INC. 296 shares at an average of $100.82, traded Sep 16, 2026, filed Sep 18, 2026.

Warning score
20
Value
$30k
296 shares
Holdings after
3,946
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    President
    +20
  • Trade size
    $30k at market
    +5
  • Share of holdings sold
    Sold 7.0% of holdings
    0
  • Cluster
    3 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CORTOct 9, 2026 · close 121.19
Since filing Sep 18, 2026: +9.9%SPY +2.2% · excess +7.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001193125-26-395837, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Sep 16, 2026SOpen-market sale
Common Stock10b5-1
-296$100.82$30k3,94623 d ago

Related signals

Other insiders at CORCEPT THERAPEUTICS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
40Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$2.9M
25,000 shares
-242%
40Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Joseph Douglas Lyon
See Remarks
$1.2M
10,000 shares
-154%
45Moderate
CORTsell 310b5-1
CORCEPT THERAPEUTICS INC
Roberto Wandenkolk Vieira
President, Oncology
$967k
8,333 shares
-68%
35Weak
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
James N Wilson
director
$1.1M
10,000 shares
-1%
40Moderate
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Joseph Douglas Lyon
See Remarks
$1.1M
10,000 shares
-64%
45Moderate
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Roberto Wandenkolk Vieira
President, Oncology
$6.5M
58,333 shares
-93%
40Moderate
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$2.9M
25,000 shares
-72%
30Weak
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Joseph K Belanoff
Chief Executive Officer
$120k
1,974 shares
-0%
5Weak
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Sean Maduck
See Remarks
$103k
1,697 shares
-2%
0Weak
CORTsell 410b5-1
CORCEPT THERAPEUTICS INC
Joseph Douglas Lyon
See Remarks
$26k
421 shares
-4%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Roberto Wandenkolk Vieira sold $30k of CORT | InsiderTell